Delivery Order SPE2DE24D0021-SPE2D625F2APW
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order contract valued at $2,934.90 on September 3, 2025, by the Defense Department's Medical Supply Chain division for the procurement of National Flu/RSV/COVID positive test kits in 6x 0.5mL Reagent Use Only (RUO) format. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and has an ultimate completion date of September 10, 2025. Performance will take place in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,196.00 by the Medical Supply Chain division of the Department of Defense on July 23, 2025. The contract, which operates under a fixed-price structure with economic price adjustment provisions, covers the supply of National Flu/RSV/COVID positive test kits in 6x0.5mL formats for research use only (RUO). This is a child contract with an ultimate completion date of July 30, 2025, and performance will be executed in...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,327.00 by the Defense Medical Supply Chain on September 19, 2025, for the provision of National Flu/RSV/COVID Positive 6x 0.5ML RUO (Research Use Only) testing supplies. The contract, which represents a child award under a larger vehicle, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September...
- Fisher Scientific Company L.L.C. received a fixed-price delivery order valued at $1,467.45 from the Medical Supply Chain, a defense-oriented federal agency, for the procurement of National Flu/RSV/COVID positive test kits (6x0.5mL, research use only). The contract, awarded on July 28, 2025, with an ultimate completion date of August 4, 2025, represents a child contract under a larger vehicle and will be performed in Pittsburgh, PA. This award reflects Fisher Scientific's established role as a...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,137.88 on September 10, 2025, by the Medical Supply Chain division of the Department of Defense to supply National Flu/RSV/COVID positive controls in 6x0.5ml format for research use only (RUO). This is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of September 17, 2025. The contract will be performed in Pittsburgh, Pennsylvania. This award represents a child contract...
- Fisher Scientific Company L.L.C. was awarded a delivery order on August 20, 2025, for the procurement of National Flu/RSV/COVID positive test kits in 6x0.5ml configurations for research use only (RUO). This fixed-price delivery order with economic price adjustment carries a ceiling value of $1,327.00 and is set to be completed by August 27, 2025. The contract will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania, and was awarded by the Defense-focused Medical Supply Chain...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,270.00 for the supply of National Flu/RSV/COVID Positive control materials in 6x0.5mL quantities designated for Research Use Only (RUO). The award, issued on April 21, 2025, with an ultimate completion date of April 23, 2025, represents a child contract under a larger vehicle and was funded by the Department of Defense's Medical Supply Chain division. The contract was awarded without a set-aside designation through...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,061.60 on September 5, 2025, for the supply of National Flu/RSV/COVID Positive controls in 6x0.5mL format for research use only (RUO). This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of September 12, 2025. The award was made without a set-aside designation through open competition by the Medical Supply Chain, a defense-focused federal...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on July 14, 2025, valued at $2,934.90 for the supply of National Flu/Respiratory Syncytial Virus/COVID-19 positive controls in 6x 0.5 milliliter research use only (RUO) format. The contract is fixed-price with economic price adjustment provisions and will be fulfilled at the vendor's Pittsburgh, Pennsylvania location, with an ultimate completion date of July 21, 2025. This delivery order represents a child contract with no...
- The U.S. Defense Department's Medical Supply Chain division awarded Fisher Scientific Company L.L.C. a delivery order valued at $3,080 for antigen COVID-19 testing kits on August 20, 2025, with an ultimate completion date of August 27, 2025. The contract is structured as fixed price with economic price adjustment and will be performed in Pittsburgh, Pennsylvania. This award was made through open competition with no set-aside designations, reflecting Fisher Scientific's established capability...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F2APWDelivery Order
Fisher Scientific Company L.L.C., a major supplier of scientific products and laboratory supplies to federal agencies, was awarded a delivery order on August 27, 2025, for the supply of National Flu/RSV/COVID positive test materials in 6x5ml configurations for research or use only (RUO). The contract, valued at $1,467.45, was awarded by the Medical Supply Chain division of the Department of Defense without a set-aside designation, reflecting open competition. As a child contract under a larger vehicle, this delivery order represents a fixed-price agreement with economic price adjustment provisions, with a completion date of September 4, 2025. The materials will be delivered to Pittsburgh, Pennsylvania. Fisher Scientific's extensive federal contracting history demonstrates its established capabilities in providing specialized laboratory and diagnostic supplies. The company maintains significant contracts across multiple federal agencies, including the National Institutes of Health, Department of Veterans Affairs, and the Food and Drug Administration. This award for respiratory and infectious disease diagnostic materials aligns with the company's core competencies in supplying testing solutions and scientific reagents to support federal healthcare and research initiatives, particularly in response to emerging public health priorities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/27/25 |